Predictive analytics in mental health: Applications, guidelines, challenges and perspectives

Molecular Psychiatry

Volumn 22, Issue 1, 2017, Pages 37-43

  Hahn, T ^a   Nierenberg, A A ^b   Whitfield Gabrieli, S ^c  

^a GOETHE UNIVERSITY   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; METHYLPHENIDATE;

ATTENTION DEFICIT DISORDER; BIPOLAR DISORDER; DATA PROCESSING; DIFFERENTIAL DIAGNOSIS; GENOME-WIDE ASSOCIATION STUDY; HUMAN; MACHINE LEARNING; MAJOR DEPRESSION; MENTAL DISEASE; NEUROIMAGING; PATIENT INFORMATION; PERSONALIZED MEDICINE; PREDICTION; PRIORITY JOURNAL; PRODROMAL SYMPTOM; REVIEW; SCHIZOPHRENIA; TREATMENT RESPONSE; FORECASTING; MENTAL HEALTH; PROCEDURES; PSYCHIATRY; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; TRENDS;

FORECASTING; HUMANS; MENTAL HEALTH; PRECISION MEDICINE; PSYCHIATRY;

EID: 84995470401     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2016.201     Document Type: Review

References (56)

1. Kessler RC, Aguilar-Gaxiola S, Alonso J, Chatterji S, Lee S, Ormel J et al. The global burden of mental disorders: an update from the WHO World Mental Health (WMH) surveys. Epidemiol Psichiatr Soc 2009; 18: 23-33.
2. Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011; 21: 655-679.
3. Gustavsson A, Svensson M, Jacobi F, Allgulander C, Alonso J, Beghi E et al. Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2012; 22: 237-238.
4. Insel T. Assessing the economic costs of serious mental illness. Am J Psychiatry 2008; 165: 663-665.
5. Stamm K, Salize H-J. Volkswirtschaftliche Konsequenzen. In: Stoppe G, Bramesfeld A, Schwartz F-W (eds). Volkskrankheit Depression? Springer: Berlin Heidelberg, Germany, 2006, pp 109-120.
6. Dore G, Romans SE. Impact of bipolar affective disorder on family and partners. J Affect Disord 2001; 67: 147-158.
7. Gianfrancesco FD, Wang R-h YuE. Effects of patients with bipolar, schizophrenic, and major depressive disorders on the mental and other healthcare expenses of family members. Soc Sci Med 2005; 61: 305-311.
8. Guan B, Deng Y, Cohen P, Chen H. Relative impact of Axis I mental disorders on quality of life among adults in the community. J Affect Disord 2011; 131: 293-298.
9. Hasui C, Sakamoto S, Sugiura T, Miyata R, Fujii Y, Koshiishi F et al. Burden on family members of the mentally ill: a naturalistic study in Japan. Compr Psychiatry 2002; 43: 219-222.
10. Olatunji BO, Cisler JM, Tolin DF. Quality of life in the anxiety disorders: a meta-analytic review. Clin Psychol Rev 2007; 27: 572-581.
11. Saunders JC. Families living with severe mental illness: a literature review. Issues Ment Health Nurs 2003; 24: 175-198.
12. Wittmund B, Wilms HU, Mory C, Angermeyer MC. Depressive disorders in spouses of mentally ill patients. Soc Psychiatry Psychiatr Epidemiol 2002; 37: 177-182.
13. Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gesse S, Bloom LR, Fathima S et al. The Global Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum. 2011, available from: http://www3.weforum.org/docs/WEF- Harvard-HE-GlobalEconomicBurdenNonCommunicableDiseases-2011.pdf.
14. Stephan KE, Bach DR, Fletcher PC, Flint J, Frank MJ, Friston KJ et al. Charting the landscape of priority problems in psychiatry, part 1: classification and diagnosis. Lancet Psychiatry 2016; 3: 77-83.
15. Darcy AM, Louie AK, Roberts LW. Machine learning and the profession of medicine. JAMA 2016; 315: 551-552.
16. Eyre HA, Singh AB, Reynolds C 3rd. Tech giants enter mental health. World Psychiatry 2016; 15: 21-22.
17. Gabrieli JD, Ghosh SS, Whitfield-Gabrieli S. Prediction as a humanitarian and pragmatic contribution from human cognitive neuroscience. Neuron 2015; 85: 11-26.
18. Jordan MI, Mitchell TM. Machine learning: trends, perspectives, and prospects. Science 2015; 349: 255-260.
19. Wolfers T, Buitelaar JK, Beckmann CF, Franke B, Marquand AF. From estimating activation locality to predicting disorder: a review of pattern recognition for neuroimaging-based psychiatric diagnostics. Neurosci Biobehav Rev 2015; 57: 328-349.
20. Eley TC, Hudson JL, Creswell C, Tropeano M, Lester KJ, Cooper P et al. Therapygenetics: the 5HTTLPR and response to psychological therapy. Mol Psychiatry 2012; 17: 236-237.
21. Hou L, Heilbronner U, Degenhardt F, Adli M, Akiyama K, Akula N et al. Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study. Lancet 2016; 387: 1085-1093.
22. DeRubeis RJ, Siegle GJ, Hollon SD. Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. Nat Rev Neurosci 2008; 9: 788-796.
23. Paulus MP. Pragmatism instead of mechanism: a call for impactful biological psychiatry. JAMA Psychiatry 2015; 72: 631-632.
24. Marcus G, Davis E. (2014). Eight (No, Nine!) Problems With Big Data. In Sulzberger AOJ (ed). The New York Times: New York, NY, USA, p A23.
25. Chan MK, Gottschalk MG, Haenisch F, Tomasik J, Ruland T, Rahmoune H et al. Applications of blood-based protein biomarker strategies in the study of psychiatric disorders. Prog Neurobiol 2014; 122: 45-72.
26. Fu CH, Costafreda SG. Neuroimaging-based biomarkers in psychiatry: clinical opportunities of a paradigm shift. Can J Psychiatry 2013; 58: 499-508.
27. Hofmann-Apitius M, Ball G, Gebel S, Bagewadi S, de Bono B, Schneider R et al. Bioinformatics mining and modeling methods for the identification of disease mechanisms in neurodegenerative disorders. Int J Mol Sci 2015; 16: 29179-29206.
28. McMahon FJ. Prediction of treatment outcomes in psychiatry-where do we stand? Dialogues Clin Neurosci 2014; 16: 455-464.
29. Savitz JB, Rauch SL, Drevets WC. Clinical application of brain imaging for the diagnosis of mood disorders: the current state of play. Mol Psychiatry 2013; 18: 528-539.
30. Scarr E, Millan MJ, Bahn S, Bertolino A, Turck CW, Kapur S et al. Biomarkers for psychiatry: the journey from fantasy to fact, a report of the 2013 CINP Think Tank. International Journal of Neuropsychopharmacology 2015; 18: pyv042.
31. Veronese E, Castellani U, Peruzzo D, Bellani M, Brambilla P. Machine learning approaches: from theory to application in schizophrenia. Comput Math Methods Med 2013; 2013: 867924.
32. National Research Council (US) Committee on A Framework for Developing a New Taxonomy of Disease. Toward precision medicine: building a knowledge network for biomedical research and a new taxonomy of disease. National Academies Press: Washington DC, 2011.
33. Mirnezami R, Nicholson J, Darzi A. Preparing for precision medicine. N Engl J Med 2012; 366: 489-491.
34. Lin CF, Wang SD. Fuzzy support vector machines. IEEE Trans Neural Netw 2002; 13: 464-471.
35. Qin ZC, Lawry J. Decision tree learning with fuzzy labels. Inform Sci 2005; 172: 91-129.
36. Regier DA, Narrow WE, Kuhl EA, Kupfer DJ. The conceptual development of DSM-V. Am J Psychiatry 2009; 166: 645-650.
37. Hastie T, Tibshirani R, Friedman J, Franklin J. The elements of statistical learning: data mining, inference and prediction. Math Intell 2005; 27: 83-85.
38. Ozomaro U, Wahlestedt C, Nemeroff CB. Personalized medicine in psychiatry: problems and promises. BMC Med 2013; 11: 132.
39. Huys QJM, Maia TV, Frank MJ. Computational psychiatry as a bridge from neuroscience to clinical applications. Nat Neurosci 2016; 19: 404-413.
40. Ofer D, Linial M. ProFET: feature engineering captures high-level protein functions. Bioinformatics 2015; 31: 3429-3436.
41. MacKay DJC. Information Theory, Inference, and Learning Algorithms. Cambridge University Press: Cambridge, UK; New York, NY, USA, 2003.
42. Bedi G, Carrillo F, Cecchi GA, Slezak DF, Sigman M, Mota NB et al. Automated analysis of free speech predicts psychosis onset in high-risk youths. NPJ Schizophr 2015; 1: 15030.
43. Hahn T, Kircher T, Straube B, Wittchen HU, Konrad C, Strohle A et al. Predicting treatment response to cognitive behavioral therapy in panic disorder with agoraphobia by integrating local neural information. JAMA Psychiatry 2015; 72: 68-74.
44. LeCun Y, Bengio Y, Hinton G. Deep learning. Nature 2015; 521: 436-444.
45. Building High-Level Features Using Large Scale Unsupervised Learning. IEEE International Conference on Proceedings of the Acoustics, Speech and Signal Processing (ICASSP): Vancouver, BC, 2013, pp 8595-8598.
46. Kendler KS. The nature of psychiatric disorders. World Psychiatry 2016; 15: 5-12.
47. Maj M. The need for a conceptual framework in psychiatry acknowledging complexity while avoiding defeatism. World Psychiatry 2016; 15: 1-2.
48. Hahn T, Marquand AF, Ehlis AC, Dresler T, Kittel-Schneider S, Jarczok TA et al. Integrating neurobiological markers of depression. Arch Gen Psychiatry 2011; 68: 361-368.
49. Bishop CM. Pattern Recognition and Machine Learning. Springer: New York, NY, USA, 2006.
50. Collins FS, Hudson KL, Briggs JP, Lauer MS. PCORnet: turning a dream into reality. J Am Med Inform Assn 2014; 21: 576-577.
51. Pine DS, Leibenluft E. Biomarkers with a mechanistic focus. JAMA Psychiatry 2015; 72: 633-634.
52. Pereira F, Mitchell T, Botvinick M. Machine learning classifiers and fMRI: a tutorial overview. Neuroimage 2009; 45: S199-S209.
53. Yang Z, Fang F, Weng X. Recent developments in multivariate pattern analysis for functional MRI. Neurosci Bull 2012; 28: 399-408.
54. Lueken U, Hahn T. Functional neuroimaging of psychotherapeutic processes in anxiety and depression: from mechanisms to predictions. Curr Opin Psychiatry 2016; 29: 25-31.
55. Lazer D, Kennedy R, King G, Vespignani A. Big data. The parable of Google Flu: traps in big data analysis. Science 2014; 343: 1203-1205.
56. Wolpert DH. The lack of a priori distinctions between learning algorithms. Neural Comput 1996; 8: 1341-1390.